INTERNATIONAL PATENT: ATXA THERAPEUTICS LIMITED FILES APPLICATION FOR "DRUG-IN-CAPSULE FORMULATIONS OF THROMBOXANE RECEPTOR ANTAGONISTS"

GENEVA, Oct. 4 -- ATXA THERAPEUTICS LIMITED (UCD Conway InstituteUniversity College DublinBelfieldDublin 4) filed a patent application (PCT/EP2025/058575) for "DRUG-IN-CAPSULE FORMULATIONS OF THROMBOXANE RECEPTOR ANTAGONISTS" on Mar 28, 2025. With publication no. WO/2025/202463, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KINSELLA, B. Theresa (c/o ATXA Therapeutics LimitedUCD Conway InstituteBelfieldDublin 4), REID, Helen (c/o ATXA Therapeutics LimitedUCD Conway InstituteUniversity College DublinBelfield, Dublin 4)

A...